Brought to you by 
Gene Logic, Wyeth-Ayerst sign drug toxicity collaboration
13 Jul 1999
Executive Summary
Gene Logic will combine its gene expression and bioinformatics technologies with Wyeth-Ayerst's compounds and expertise in toxicology to develop a database of gene expression profiles predictive of different classes of drug toxicity.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- Product or Technology Swap
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Gene Logic, Wyeth-Ayerst sign drug toxicity collaboration
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice